PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.34
ESG score 90-95% of RNAZ's 63.80. Bill Ackman would demand clear ESG improvement catalysts.
58.68
Environmental score 1.1-1.2x RNAZ's 54.62. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
58.17
Social score 80-90% of RNAZ's 66.59. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
61.16
Governance score 80-90% of RNAZ's 70.20. Walter Schloss would scrutinize management accountability and board independence.